| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 54.176 | 47.212 | 9.172 | 10.998 | 9.758 | 16.971 | 24.556 | 23.187 | 25.557 |
| Total Income - EUR | 0 | 54.323 | 47.293 | 9.172 | 11.027 | 9.811 | 16.971 | 24.556 | 23.187 | 25.557 |
| Total Expenses - EUR | 913 | 34.320 | 33.015 | 5.252 | 3.565 | 3.451 | 7.446 | 11.519 | 20.751 | 19.285 |
| Gross Profit/Loss - EUR | -913 | 20.003 | 14.278 | 3.920 | 7.462 | 6.359 | 9.526 | 13.036 | 2.436 | 6.272 |
| Net Profit/Loss - EUR | -913 | 18.916 | 13.805 | 3.645 | 7.132 | 6.065 | 9.078 | 12.520 | 2.232 | 5.620 |
| Employees | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Indago Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 158 | 0 | 1.898 | 1.420 | 957 | 593 | 20.241 | 14.332 | 8.397 | 2.839 |
| Current Assets | 189 | 10.477 | 12.741 | 6.213 | 13.927 | 9.757 | 11.930 | 14.506 | 3.075 | 12.842 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 876 | 1.923 | 0 | 621 | 953 | 0 | 9.115 | 67 | 3.438 |
| Cash | 189 | 9.601 | 10.818 | 6.213 | 13.306 | 8.804 | 11.930 | 5.392 | 3.008 | 9.404 |
| Shareholders Funds | -733 | 2.733 | 13.989 | 7.424 | 14.412 | 9.759 | 18.620 | 12.715 | 5.846 | 5.813 |
| Social Capital | 180 | 178 | 175 | 172 | 169 | 165 | 162 | 162 | 162 | 161 |
| Debts | 1.080 | 7.744 | 650 | 208 | 472 | 591 | 13.551 | 16.123 | 5.626 | 9.867 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Indago Med Srl